Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,638,472
-
Share change
-
+2,873,113
-
Total reported value
-
$276,460,341
-
Price per share
-
$16.65
-
Number of holders
-
58
-
Value change
-
+$13,512,862
-
Number of buys
-
33
-
Number of sells
-
34
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q4 2018
As of 31 Dec 2018,
AVROBIO INC - COM (AVRO) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,638,472 shares.
The largest 10 holders included
Blackstone Group L.P., SV Health Investors, LLC, CITADEL ADVISORS LLC, Cormorant Asset Management, LP, EVENTIDE ASSET MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Aisling Capital Management LP, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.